The US FDA conducted the inspection at Ipca Laboratories Ltd's Formulations manufacturing Unit situated at Piparia (Silvassa) from 19th August, 2019 to 23rd August, 2019. At the conclusion of the inspection, the US FDA issued a Form 483 with 3 (three) observations.
The Company shall be submitting its comprehensive response on these observations to the US FDA within the stipulated time frame.
The Company is committed to address these observations promptly.
Shares of IPCA LABORATORIES LTD. was last trading in BSE at Rs.957.9 as compared to the previous close of Rs. 958.7. The total number of shares traded during the day was 4515 in over 531 trades.
The stock hit an intraday high of Rs. 960.95 and intraday low of 949.65. The net turnover during the day was Rs. 4325641.